头孢达肟
![]() | |
临床资料 | |
---|---|
ATC码 |
|
识别信息 | |
| |
CAS号 | 80195-36-4 ![]() |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
化学信息 | |
化学式 | C14H15N5O6S2 |
摩尔质量 | 413.434 g/mol |
3D模型(JSmol) | |
| |
|
头孢达肟(其国际非专利药品名称为“Cefdaloxime”)是一种第三代头孢菌素[1][2]。
参考资料
- ^ Sader HS, Runyon BA, Erwin ME, Jones RN. Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis. Diagnostic Microbiology and Infectious Disease. February 1995, 21 (2): 105–10. PMID 7628189. doi:10.1016/0732-8893(94)00148-p.
- ^ Jones, R N; Erwin, M E. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin. Journal of Clinical Microbiology (American Society for Microbiology). 1992, 30 (5): 1297–1300. ISSN 0095-1137. doi:10.1128/jcm.30.5.1297-1300.1992.
![]() | 这是一篇与合成抗生素相关小作品。您可以通过编辑或修订扩充其内容。 |
|